[ABO incompatibility and non myeloablative allogeneic stem cell transplantation]

Area of Science:

• Hematology
• Immunology
• Transplantation Science

Background:

• ABO incompatibility presents challenges in allogeneic hematopoietic stem cell transplantation (HSCT).
• Major ABO incompatibility is linked to delayed erythroid engraftment and pure red cell aplasia.
• Minor ABO incompatibility can cause acute hemolytic reactions post-transplant.

Purpose of the Study:

• To review the clinical and therapeutic aspects of ABO incompatibility in HSCT.
• To analyze the impact of conditioning regimen intensity on ABO incompatibility management.
• To explore how conditioning regimens affect complications in major and minor ABO mismatches.

Main Methods:

• Literature review focusing on ABO incompatibility in HSCT.
• Analysis of clinical outcomes related to ABO mismatch.
• Evaluation of conditioning regimens and their influence on complications.

Main Results:

• Non-myeloablative conditioning may increase pure red cell aplasia in major ABO mismatch due to persistent host antibodies.
• Peripheral blood stem cells and graft-versus-host disease prophylaxis affect hemolytic reactions in minor ABO mismatch.
• Conditioning intensity is a key factor in managing ABO incompatibility.

Conclusions:

• ABO incompatibility requires careful management in HSCT.
• Conditioning regimens play a critical role in modulating ABO incompatibility complications.
• Optimizing conditioning strategies is essential for improving HSCT outcomes in ABO-incompatible settings.